Deals review
- Deals review
- Deal details
DuPont to acquire CombiChem
In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Related deals
CombiChem and Chromagen enter assay development and screening agreement
DuPont Completes Purchase of Maxygen Subsidiary Verdia
ChemRx and DuPont sign chemical library agreement
DuPont licenses new fungicide from Mitsui
Syngene and DuPont Crop Protection Forge Alliance Partnership
DuPont Acquires Cardinal’s Industrial Apparel Business
DuPont and Pharmasset announce collaboration
DuPont and FOSS Announce Joint Agreement to Enhance Ethanol Production
DuPont agrees licenses for Cre-lox technology
DuPont and 3-Dimensional Pharmaceuticals announce drug discovery collaboration
More deals
Latest deals
- Biovator and BASF sign technology development agreement
- Agfa HealthCare signs four-year agreement with Chinese partners for distribution of radiography solutions, potentially worth 500 million US dollar
- Omnicare Announces Acquisition of Continuing Care Rx
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program
Most viewed deals
- Recommended acquisition of Acambis plc ("Acambis") by Sanofi Pasteur Holding ("Sanofi Pasteur") by way of scheme of arrangement Posting of Scheme Document
- Omnicare Announces Acquisition of Continuing Care Rx
- Bayer CropScience and Janssen PMP conclude research agreement:
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- Biovator and BASF sign technology development agreement
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us